Details for New Drug Application (NDA): 211925
✉ Email this page to a colleague
NDA 211925 describes CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE, which is a drug marketed by Anda Repository, Chartwell Rx, Heritage Pharma, Micro Labs, Mylan Pharms Inc, Tp Anda Holdings, and Usl Pharma, and is included in ten NDAs. It is available from two suppliers. Additional details are available on the CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE profile page.
The generic ingredient in CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE is amitriptyline hydrochloride; chlordiazepoxide. There are thirteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amitriptyline hydrochloride; chlordiazepoxide profile page.
The generic ingredient in CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE is amitriptyline hydrochloride; chlordiazepoxide. There are thirteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amitriptyline hydrochloride; chlordiazepoxide profile page.
Summary for 211925
| Tradename: | CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE |
| Applicant: | Micro Labs |
| Ingredient: | amitriptyline hydrochloride; chlordiazepoxide |
| Patents: | 0 |
Suppliers and Packaging for NDA: 211925
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride; chlordiazepoxide | TABLET;ORAL | 211925 | ANDA | Micro Labs Limited | 42571-302 | 42571-302-01 | 100 TABLET in 1 BOTTLE (42571-302-01) |
| CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride; chlordiazepoxide | TABLET;ORAL | 211925 | ANDA | Micro Labs Limited | 42571-302 | 42571-302-05 | 500 TABLET in 1 BOTTLE (42571-302-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 12.5MG BASE;5MG | ||||
| Approval Date: | Feb 2, 2022 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE;10MG | ||||
| Approval Date: | Feb 2, 2022 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
